Alan M. Garber

Insider Reports History

Location
Mountain View, CA
Signature
/s/ Christiana Stevenson, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Alan M. Garber:

Company Role Class Num Shares Value Price $ Report Date Ownership
VERTEX PHARMACEUTICALS INC / MA Director Common Stock 6,872 $3,327,559 $484.22 01 May 2025 Direct
EXELIXIS, INC. Director Common Stock 35,703 $857,229 $24.01 21 Mar 2024 Direct
VERTEX PHARMACEUTICALS INC / MA Director Stock Option (Right to Buy) 1,199 $400,731 $127.54 01 May 2025 Direct
EXELIXIS, INC. Director Option (right to buy) 0 21 Mar 2024 Direct

Insider Reports Filed by Alan M. Garber

Symbol Company Period Transactions Value $ Form Type Role Filing Time
VRTX VERTEX PHARMACEUTICALS INC / MA 01 May 2025 2 $0 4 Director 05 May 2025, 16:19
VRTX VERTEX PHARMACEUTICALS INC / MA 01 May 2024 1 $0 4 Director 03 May 2024, 16:11
EXEL EXELIXIS, INC. 21 Mar 2024 3 -$1,393 4 Director 25 Mar 2024, 19:31
EXEL EXELIXIS, INC. 01 Jun 2023 1 $0 4 Director 02 Jun 2023, 21:24
VRTX VERTEX PHARMACEUTICALS INC / MA 01 May 2023 2 $0 4 Director 03 May 2023, 16:52
EXEL EXELIXIS, INC. 21 Feb 2023 3 -$447,600 4 Director 23 Feb 2023, 20:08
EXEL EXELIXIS, INC. 26 May 2022 1 $0 4 Director 27 May 2022, 20:15
VRTX VERTEX PHARMACEUTICALS INC / MA 01 May 2022 1 $0 4 Director 03 May 2022, 16:42
EXEL EXELIXIS, INC. 01 Mar 2022 3 -$322,121 4 Director 03 Mar 2022, 19:07
EXEL EXELIXIS, INC. 27 May 2021 1 $0 4 Director 28 May 2021, 20:17